Table 1.
The expression of miR-32 in patients and the tumor’s clinical and pathological characteristics
| Factors | Total (n=132) | High (n=102) | Low (n=30) | Significance |
|---|---|---|---|---|
| Age (mean ± SD) | 59.7±8.1 | 67.4±9.9 | No | |
| Sex | No | |||
| Male | 78 | 62 | 16 | |
| Female | 54 | 40 | 14 | |
| Histological degree | No | |||
| Good | 70 | 57 | 13 | |
| Average and poor | 62 | 45 | 17 | |
| Size of tumor | Yes* | |||
| Small (<25 mm) | 47 | 35 | 12 | |
| Large (≥25 mm) | 85 | 67 | 18 | |
| Depth of tumor invasion | Yes* | |||
| T1 | 51 | 38 | 13 | |
| T2 or T3 | 81 | 64 | 17 | |
| Lymphatic invasion | Yes* | |||
| Existence | 69 | 55 | 14 | |
| Nonexistence | 63 | 47 | 16 | |
| Stage | No | |||
| I, II | 67 | 52 | 15 | |
| III, IV | 65 | 50 | 15 |
Note:
*
P<0.05.
Abbreviations: miR-32, microRNA; SD, standard deviation.